COMMUNIQUÉS West-GlobeNewswire

Notice of extraordinary general meeting in Aino Health AB (publ.)

01/09/2017 - 08:30

The shareholders in Aino Health AB (publ) reg. no. 559063-5073 (the "Company") are hereby convened to the extraordinary general meeting on Tuesday October 3, 2017, at 05:00 p.m. at Grand Hotel, Bantorget 1, 222 29 Lund [...]

Aino Health AB (publ): proposes changes to the Board

01/09/2017 - 08:30

Aino Health AB gears its Board's expertise by nominating Liselotte Bergmark as a new Board member, to be elected at an extraordinary general meeting. Liselotte Bergmark will provide the Board with international branch [...]

Verona Pharma Appoints Stifel as Nominated Adviser

01/09/2017 - 08:00

LONDON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

DBV Technologies to Attend Upcoming Investor Conferences

01/09/2017 - 07:30

Press Release Montrouge, France, September 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]

DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs

01/09/2017 - 07:30

Communiqué de Presse Montrouge, France, 1 Septembre 2017, 7h30 CEST DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : [...]

ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB

01/09/2017 - 07:30

Leuven, Belgium 1 September 2017 - ONCURIOUS NV, a Belgium-based biotech company focusing on the development of innovative oncology treatments, today announces that it has reached principle agreement with VIB to acquire [...]

Taconic Biosciences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability

31/08/2017 - 23:22

HUDSON, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse model to study Kabuki [...]

NANOBIOTIX : Résultats semestriels au 30 juin 2017

31/08/2017 - 19:29

Résultats semestriels au 30 juin 2017 Paris, France, et Cambridge, Massachusetts (USA) le 31 août 2017 - NANOBIOTIX (Euronext : NANO - ISIN : FR0011341205), société française pionnière en nanomédecine développant de [...]

NANOBIOTIX half year results for the six months ended 30 June 2017

31/08/2017 - 19:29

Nanobiotix half year results for the six months ended 30 June 2017 Paris, France and Cambridge, Massachusetts, USA, August 31, 2017 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine [...]

EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU

31/08/2017 - 19:00

Dr. S. Scionti, Medical Director of Vituro and most experienced HIFU urologist in the U.S. to start treating with Ablatherm in September LYON, France, August 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in [...]

AB Science annonce ses résultats semestriels au 30 juin 2017

31/08/2017 - 18:02

Paris, le 31 août 2017, 18h Perte nette de 13,5M€ au premier semestre 2017, en baisse de 8,4% par rapport au premier semestre 2016(14,7M€), en raison de la diminution des coûts de R&D Trésorerie de 49,3M€ au 30 juin [...]

AB Science reports its revenue for the first half of 2017

31/08/2017 - 18:02

Paris, August 31 2017, 6pm Net loss of 13.5M€ in the first half of 2017, a decrease of 8.4% as compared with the first half of 2016 (14.7M€), due to R&D costs decrease Cash position of 49.3M€ as of 30 June 2017, [...]

Summit Therapeutics plc : Half-yearly report

31/08/2017 - 13:00

Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 31 JULY 2017 AND OPERATIONAL PROGRESS Conference Call Scheduled [...]

Apricus Biosciences Announces FDA Acknowledgement of Vitaros(TM) Class 2 NDA Resubmission

31/08/2017 - 13:00

PDUFA Goal Date of February 17, 2018 SAN DIEGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today [...]

MPI: MPI publishes Half-year Report for the first half of 2017

31/08/2017 - 11:07

Hoersholm, Denmark, August 31, 2017 - Medical Prognosis Institute A/S ("MPI") announces the company's Half-year report for the period January-June 2017. The report is available as an attached document to this press [...]

Xbrane Biopharma releases interim report for the period April - June 2017

31/08/2017 - 10:31

Press release 2017-08-31 Xbrane Biopharma ABs interim report for the period April - June 2017 is now available on the Company's website, www.xbrane.com . April to June Net sales SEK 4,514 thousand (1,032) Total income [...]

Ambu A/S: Articles of Association August 2017

31/08/2017 - 10:07

Articles of Association August 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Ambu A/S: Capital increase in connection with exercise of warrants issued

31/08/2017 - 09:15

Company announcement no. 16_2016_17 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Total number of shares and voting rights in Zealand at August 31, 2017

31/08/2017 - 08:46

Company announcement - No. 42 / 2017 Total number of shares and voting rights in Zealand at August 31, 2017 Copenhagen, August 31, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' [...]